teriflunomide 14 mg Tablet, Film Coated, 5-count — NDC 12579-186-05 (Billing 12579-0186-05)
This is a package of 5 tablets of teriflunomide 14 mg Tablet, Film Coated from OPELLA HEALTHCARE INTERNATIONAL SAS, first listed with the FDA Sep 2012 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.
NDC database record
One package, one record: these facts belong to NDC 12579-186-05 alone.
- Record
- FDA NDC Directory package listing · Drug for further processing
- Code segments
- 12579 labeler · 186 product · 05 package
- Package marketed since
- Sep 13, 2012
- Listing certified through
- Dec 31, 2026
- Barcode (UPC-A, from the NDC)
- 3 1257918605 5
- FDA record last changed
- Jul 24, 2026
Other active recalls for Teriflunomide (different manufacturers) — 1 · tap to view
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
- It treats relapsing forms of multiple sclerosis in adults. That includes a first episode of MS-like symptoms, relapsing-remitting MS, and active secondary progressive MS. It's sold...
- Take one tablet by mouth once a day. You can take it with or without food. Follow your prescriber's directions and your pharmacy label for the exact dose.
- The most common are headache, diarrhea, nausea, hair thinning, tingling or numbness, and joint pain. Your liver enzymes may also rise on blood tests. Call your doctor if you notice...
- Teriflunomide can injure the liver and lower your white blood cells. Your liver tests are checked before you start and at least monthly for six months. A blood count, tuberculosis...
Patient education
Drug interactions
Supplement & herbal interactions
Some supplements/herbs that may interact with Teriflunomide — tap one for details:
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 12579-0186-05 You're viewing this Main listing | 5 TABLET, FILM COATED in 1 BLISTER PACK | — | — | Active |
| 12579-0186-14 12579-186-14 | 14 TABLET, FILM COATED in 1 BLISTER PACK | — | — | Active |
You're viewing the smallest of 2 pack sizes for this product.
Pack size FAQ
What quantity is in this package?
How does this package differ from NDC 12579-0186-14?
What NDC number is used to bill for this package of teriflunomide 14 mg Tablet, Film Coated?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Teriflunomide 14 mg 31722-0247-30 | Camber | 30 tablets | $0.223 | AB | Availability likely | — |
| Teriflunomide 14 mg 70377-0018-11 | Biocon | 30 tablets | $0.223 | AB | Availability likely | — |
| Teriflunomide 14 mg 70710-1115-03 | Zydus | 30 tablets | $0.223 | AB | Availability likely | — |
| Teriflunomide 14 mg 00480-3156-56 | Teva | 30 tablets | $0.223 | AB | Availability likely | — |
| Teriflunomide 14 mg 16729-0400-10 | Accord | 30 tablets | $0.693 | AB | FDA listed | — |
| Teriflunomide 14 mg 00378-0628-93 | Mylan | 30 tablets | — | — | FDA listed | — |
| Teriflunomide 14 mg 46708-0314-14 | Alembic | 14 tablets | — | AB | FDA listed | — |
| Teriflunomide 14 mg 69339-0170-03 | Natco | 30 tablets | — | AB | FDA listed | — |
| Teriflunomide 14 mg 69539-0033-41 | MSN | 14 tablets | — | AB | FDA listed | — |
| Teriflunomide 14 mg 69539-0316-30 | MSN | 30 tablets | — | AB | FDA listed | — |
| Teriflunomide 14 mg 42291-0831-30 | AvKARE | 30 tablets | — | AB | FDA listed | — |
| Teriflunomide 14 mg 59651-0055-28 | Aurobindo | 28 tablets | — | AB | FDA listed | — |
| teriflunomide 14 mg 12579-0191-00 | OPELLA | 200000 tablets | — | — | FDA listed | — |
| Teriflunomide 14 mg 62332-0314-14 | Alembic | 14 tablets | — | AB | FDA listed | — |
| Teriflunomide 14 mg 70771-1011-03 | Zydus | 30 tablets | — | AB | FDA listed | — |
| Aubagio 14 mg 58468-0210-01 | Genzyme | 5 tablets | — | AB | FDA listed | — |
| teriflunomide 14 mg 68462-0424-15 | Glenmark | 14 tablets | — | AB | FDA listed | — |
| teriflunomide 14 mgthis 12579-0186-05 | OPELLA | 5 tablets | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Teriflunomide inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from OPELLA HEALTHCARE INTERNATIONAL SAS labeler code 12579
- glyburide 2.5 mg Tablet NDC 12579-055-00
- glyburide 5 mg Tablet NDC 12579-056-00
- Levocetirizine Dihydrochloride 5 mg Tablet NDC 12579-180-00
- fexofenadine hydrochloride 60 mg Tablet, Film Coated, Extended Release NDC 12579-181-01
- Fexofenadine Hydrochloride 180 mg Tablet, Film Coated, Extended Release NDC 12579-182-00
- teriflunomide 7 mg Tablet, Film Coated NDC 12579-185-05
- Fexofenadine Hydrochloride 30 mg Tablet, Orally Disintegrating NDC 12579-188-00
- Fexofenadine Hydrochloride 180 mg Tablet, Film Coated, Extended Release NDC 12579-189-00
- teriflunomide 7 mg Tablet, Film Coated NDC 12579-190-00
- teriflunomide 14 mg Tablet, Film Coated NDC 12579-191-00
- Tadalafil 5 mg Tablet, Coated NDC 12579-200-00
- bisacodyl 5 mg Tablet, Coated NDC 12579-228-00
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full FDA label FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Medicare Part D spend CMS · PART D · 2026 (Q1)
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What "drug for further processing" means
FDA lists this package under the "drug for further processing" marketing category: OPELLA HEALTHCARE INTERNATIONAL SAS supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |